OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 2070-AK85 View EO 12866 Meetings | Received Date: 11/02/2023 |
| Title: N-Methylpyrrolidone (NMP); Regulation under the Toxic Substances Control Act (TSCA) | |
| Agency/Subagency: EPA / OCSPP | Stage: Proposed Rule |
| Concluded Action: Consistent with Change | Concluded Date: 05/28/2024 |
| Legal Deadline: None | Economically Significant: No |
| Publication Date: | Unfunded Mandates: Private Sector |
| Major: Yes | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: Yes | Small Entities Affected: Businesses |
| Federalism Implications: Yes | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: No | |
An official website of the United States government



